Chimeric RNAs as potential biomarkers for tumor diagnosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Cancers claim millions of lives each year. Early detection that can enable a higher chance of cure is of paramount importance to cancer patients. However, diagnostic tools for many forms of tumors have been lacking. Over the last few years, studies of chimeric RNAs as biomarkers have emerged. Numerous reports using bioinformatics and screening methodologies have described more than 30,000 expressed sequence tags (EST) or cDNA sequences as putative chimeric RNAs. While cancer cells have been well known to contain fusion genes derived from chromosomal translocations, rearrangements or deletions, recent studies suggest that trans-splicing in cells may be another source of chimeric RNA production. Unlike cis-splicing, trans-splicing takes place between two pre-mRNA molecules, which are in most cases derived from two different genes, generating a chimeric non-co-linear RNA. It is possible that trans-splicing occurs in normal cells at high frequencies but the resulting chimeric RNAs exist only at low levels. However the levels of certain RNA chimeras may be elevated in cancers, leading to the formation of fusion genes. In light of the fact that chimeric RNAs have been shown to be overrepresented in various tumors,studies of the mechanisms that produce chimeric RNAs and identification of signature RNA chimeras as biomarkers present an opportunity for the development of diagnoses for early tumor detection. (BMB reports 2012; 45(3): 133-140)
Abstract
Cancers claim millions of lives each year. Early detection that can enable a higher chance of cure is of paramount importance to cancer patients. However, diagnostic tools for many forms of tumors have been lacking. Over the last few years, studies of chimeric RNAs as biomarkers have emerged. Numerous reports using bioinformatics and screening methodologies have described more than 30,000 expressed sequence tags (EST) or cDNA sequences as putative chimeric RNAs. While cancer cells have been well known to contain fusion genes derived from chromosomal translocations, rearrangements or deletions, recent studies suggest that trans-splicing in cells may be another source of chimeric RNA production. Unlike cis-splicing, trans-splicing takes place between two pre-mRNA molecules, which are in most cases derived from two different genes, generating a chimeric non-co-linear RNA. It is possible that trans-splicing occurs in normal cells at high frequencies but the resulting chimeric RNAs exist only at low levels. However the levels of certain RNA chimeras may be elevated in cancers, leading to the formation of fusion genes. In light of the fact that chimeric RNAs have been shown to be overrepresented in various tumors,studies of the mechanisms that produce chimeric RNAs and identification of signature RNA chimeras as biomarkers present an opportunity for the development of diagnoses for early tumor detection. (BMB reports 2012; 45(3): 133-140)
참고문헌 (45)
- Akiva, P., "Transcription- mediated gene fusion in the human genome", Genome Res., 16, pp.30~36 (2006)
- Asmann, Y. W., "A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines", Nucleic Acids Res., 39, pp.e100~ (2011)
- Birney, E., "Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project", Nature, 447, pp.799~816 (2007)
- Coady, T. H., "Trans-splicing- mediated improvement in a severe mouse model of spinal muscular atrophy", J. Neurosci., 30, pp.126~130 (2010)
- Communi, D., "Cotranscription and intergenic splicing of human P2Y11 and SSF1 genes", J. Biol. Chem., 276, pp.16561~16566 (2001)
- Dotzlaw, H., "Characterization of estrogen receptor variant mRNAs from human breast cancers", Mol. Endocrinol., 6, pp.773~785 (1992)
- Edgren, H., "Identification of fusion genes in breast cancer by paired-end RNA-sequencing", Genome. Biol., 12, pp.R6~ (2011)
- Flouriot, G., "Natural trans-spliced mRNAs are generated fromthe human estrogen receptor-alpha (hER alpha) gene", J.Biol. Chem., 277, pp.26244~26251 (2002)
- Ge, H., "FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution", Bioinformatics, 27, pp.1922~1928 (2011)
- Gerstein, M. B., "What is a gene, post-ENCODE? History and updated definition", Genome Res., 17, pp.669~681 (2007)
- Gingeras, T. R., "Implications of chimaeric non-colinear transcripts", Nature, 461, pp.206~211 (2009)
- Ha, K. C., "Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines", BMC Med. Genomics, 4, pp.75~ (2011)
- Hirano, M., "Genomic organization of the mouse Msh4 gene producing bicistronic, chimeric and antisense mRNA", Gene, 342, pp.165~177 (2004)
- Horiuchi, T., "Alternative trans-splicing: a novel mode of pre-mRNA processing", Biol. Cell, 98, pp.135~140 (2006)
- Iyer, M. K., "ChimeraScan: a tool for identifying chimeric transcription in sequencing data", Bioinformatics, 27, pp.2903~2904 (2011)
- Kannan, K., "Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing", Proc. Natl. Acad. Sci. U.S.A., 108, pp.9172~9177 (2011)
- Kim, D., "TopHat-Fusion: an algorithm for discovery of novel fusion transcripts", Genome Biol., 12, pp.R72~ (2011)
- Kundu, M., "Function of the inv(16) fusion gene CBFB-MYH11", Curr. Opin. Hematol., 8, pp.201~205 (2001)
- Li, H., "Gene fusions and RNA trans-splicing in normal and neoplastic human cells", Cell. Cycle., 8, pp.218~222 (2009)
- Li, H., "A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells", Science, 321, pp.1357~1361 (2008)
- Li, X., "Short homologous sequences are strongly associated with the generation of chimeric RNAs in eukaryotes", J. Mol. Evol., 68, pp.56~65 (2009)
- Li, Y., "FusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq", Bioinformatics, 27, pp.1708~1710 (2011)
- Maher, C. A., "Transcriptome sequencing to detect gene fusions in cancer", Nature, 458, pp.97~101 (2009)
- Maher, C. A., "Chimeric transcript discovery by paired-end transcriptome sequencing", Proc. Natl. Acad. Sci. U.S.A., 106, pp.12353~12358 (2009)
- McManus, C. J., "RNA structure and the mechanisms of alternative splicing", Curr. Opin. Genet. Dev., 21, pp.373~379 (2011)
- McPherson, A., "deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data", PLoS Comput. Biol., 7, pp.e1001138~ (2011)
- Morerio, C., "Inversion (11)(p15q22) with NUP98-DDX10 fusion gene in pediatric acute myeloid leukemia", Cancer Genet. Cytogenet., 171, pp.122~125 (2006)
- Murphy, L. C., "Investigation of the origin of variant, truncated estrogenreceptor-like mRNAs identified in some humanbreast cancer biopsy samples", Breast. Cancer Res. Treat., 26, pp.149~161 (1993)
- Nacu, S., "Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples", BMC Med. Genomics, 4, pp.11~ (2011)
- Nowell, P. C., "The minute chromosome (Phl) in chronic granulocytic leukemia", Blut., 8, pp.65~66 (1962)
- Pflueger, D., "Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing", Genome. Res., 21, pp.56~67 (2011)
- Pink, J. J., "Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line", Br. J. Cancer, 75, pp.17~27 (1997)
- Pink, J. J., "A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7.", Nucleic. Acids. Res., 24, pp.962~969 (1996)
- Anthony, K., "Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome- mediated RNA trans-splicing", Hum. Mol. Genet., 18, pp.3266~3273 (2009)
- Santo, E. E., "Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma", Oncogene (2011)[DOI]
- Sboner, A., "FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data", Genome Biol., 11, pp.R104~ (2010)
- Shababi, M., "Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy", Hum. Gene. Ther., 22, pp.135~144 (2011)
- Shababi, M., "Optimization of SMN Trans-Splicing Through the Analysis of SMN Introns", J. Mol. Neurosci., 46, pp.459~469 (2012)
- Shiga, Y., "Transcriptional readthrough of Hox genes Ubx and Antp and their divergent post-transcriptional control during crustacean evolution", Evol. Dev., 8, pp.407~414 (2006)
- Skotheim, R. I., "A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis", Mol. Cancer, 8, pp.5~ (2009)
- Soda, M., "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer", Nature, 448, pp.561~566 (2007)
- Takahashi, T., "Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene", Ann. Surg. Oncol., 17, pp.889~897 (2010)
- Wechsler, D. S., "A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein", Genes Chromosomes Cancer, 36, pp.26~36 (2003)
- Yang, Y., "Spliceosome-mediated RNA trans-splicing", Mol. Ther., 12, pp.1006~1012 (2005)
- Ye, Q., "Identification of a novel FAS", ER-alpha fusion transcript expressed in human cancer cells, 2000, pp.1493, 373~377